These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38494207)

  • 1. Threading the needle: Achieving simplicity and performance in cellulose alkanoate ω-carboxyalkanoates for amorphous solid dispersion.
    Petrova SP; Mohamed MA; Wu H; Taylor LS; Edgar KJ
    Carbohydr Polym; 2024 Jun; 333():121988. PubMed ID: 38494207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and structure-property evaluation of cellulose ω-carboxyesters for amorphous solid dispersions.
    Liu H; Ilevbare GA; Cherniawski BP; Ritchie ET; Taylor LS; Edgar KJ
    Carbohydr Polym; 2014 Jan; 100():116-25. PubMed ID: 24188845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amorphous solid dispersion of nisoldipine by solvent evaporation technique: preparation, characterization, in vitro, in vivo evaluation, and scale up feasibility study.
    Chavan RB; Lodagekar A; Yadav B; Shastri NR
    Drug Deliv Transl Res; 2020 Aug; 10(4):903-918. PubMed ID: 32378174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into the Dissolution Mechanism of Ritonavir-Copovidone Amorphous Solid Dispersions: Importance of Congruent Release for Enhanced Performance.
    Indulkar AS; Lou X; Zhang GGZ; Taylor LS
    Mol Pharm; 2019 Mar; 16(3):1327-1339. PubMed ID: 30669846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhomogeneous Phase Significantly Reduces Oral Bioavailability of Felodipine/PVPVA Amorphous Solid Dispersion.
    Gao D; Zhu D; Zhou X; Dong S; Chen Y
    Mol Pharm; 2023 Jan; 20(1):409-418. PubMed ID: 36529939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elucidating the effect of crystallization on drug release from amorphous solid dispersions in soluble and insoluble carriers.
    Ojo AT; Ma C; Lee PI
    Int J Pharm; 2020 Dec; 591():120005. PubMed ID: 33132149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rifampin Stability and Solution Concentration Enhancement Through Amorphous Solid Dispersion in Cellulose ω-Carboxyalkanoate Matrices.
    Arca HÇ; Mosquera-Giraldo LI; Pereira JM; Sriranganathan N; Taylor LS; Edgar KJ
    J Pharm Sci; 2018 Jan; 107(1):127-138. PubMed ID: 28601524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amphiphilic Cellulose Ethers Designed for Amorphous Solid Dispersion via Olefin Cross-Metathesis.
    Dong Y; Mosquera-Giraldo LI; Taylor LS; Edgar KJ
    Biomacromolecules; 2016 Feb; 17(2):454-65. PubMed ID: 26714234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxypropyl cellulose stabilizes amorphous solid dispersions of the poorly water soluble drug felodipine.
    Sarode AL; Malekar SA; Cote C; Worthen DR
    Carbohydr Polym; 2014 Nov; 112():512-9. PubMed ID: 25129775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved dissolution of an enteric polymer and its amorphous solid dispersions by polymer salt formation.
    Qi Q; Taylor LS
    Int J Pharm; 2022 Jun; 622():121886. PubMed ID: 35661745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel High-Drug-Loaded Amorphous Dispersion Tablets of Posaconazole;
    Mudie DM; Stewart AM; Biswas N; Brodeur TJ; Shepard KB; Smith A; Morgen MM; Baumann JM; Vodak DT
    Mol Pharm; 2020 Dec; 17(12):4463-4472. PubMed ID: 32835489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Balancing Solid-State Stability and Dissolution Performance of Lumefantrine Amorphous Solid Dispersions: The Role of Polymer Choice and Drug-Polymer Interactions.
    Hiew TN; Zemlyanov DY; Taylor LS
    Mol Pharm; 2022 Feb; 19(2):392-413. PubMed ID: 34494842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amorphous solid dispersion of ibuprofen: A comparative study on the effect of solution based techniques.
    Ziaee A; O'Dea S; Howard-Hildige A; Padrela L; Potter C; Iqbal J; Albadarin AB; Walker G; O'Reilly EJ
    Int J Pharm; 2019 Dec; 572():118816. PubMed ID: 31678527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fed- and Fasted-State Performance of Pretomanid Amorphous Solid Dispersions Formulated with an Enteric Polymer.
    Nguyen HT; Van Duong T; Jaw-Tsai S; Bruning-Barry R; Pande P; Taneja R; Taylor LS
    Mol Pharm; 2023 Jun; 20(6):3170-3186. PubMed ID: 37220082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug Release and Nanodroplet Formation from Amorphous Solid Dispersions: Insight into the Roles of Drug Physicochemical Properties and Polymer Selection.
    Yang R; Mann AKP; Van Duong T; Ormes JD; Okoh GA; Hermans A; Taylor LS
    Mol Pharm; 2021 May; 18(5):2066-2081. PubMed ID: 33784104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-polymer-water interaction and its implication for the dissolution performance of amorphous solid dispersions.
    Chen Y; Liu C; Chen Z; Su C; Hageman M; Hussain M; Haskell R; Stefanski K; Qian F
    Mol Pharm; 2015 Feb; 12(2):576-89. PubMed ID: 25535667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulating Amorphous Solid Dispersions: Impact of Inorganic Salts on Drug Release from Tablets Containing Itraconazole-HPMC Extrudate.
    Takano R; Maurer R; Jacob L; Stowasser F; Stillhart C; Page S
    Mol Pharm; 2020 Aug; 17(8):2768-2778. PubMed ID: 31794228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating Spray Drying and Co-Precipitation as Manufacturing Processes for Amorphous Solid Dispersions of a Low T
    Solomos MA; Punia A; Saboo S; John C; Boyce CW; Chin A; Taggart RV; Smith D; Lamm MS; Schenck L
    J Pharm Sci; 2023 Aug; 112(8):2087-2096. PubMed ID: 36822272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability and solubility enhancement of ellagic acid in cellulose ester solid dispersions.
    Li B; Harich K; Wegiel L; Taylor LS; Edgar KJ
    Carbohydr Polym; 2013 Feb; 92(2):1443-50. PubMed ID: 23399175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced Biopharmaceutical Performance of Rivaroxaban through Polymeric Amorphous Solid Dispersion.
    Metre S; Mukesh S; Samal SK; Chand M; Sangamwar AT
    Mol Pharm; 2018 Feb; 15(2):652-668. PubMed ID: 29287144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.